RDS prophylaxis in preterm labor: corticosteroids and beta-mimetics association-indications and limits

Area of Science:

• Obstetrics and Gynecology
• Perinatology
• Pharmacology

Background:

• Tocolytic and corticosteroid therapies are used in high-risk pregnancies.
• Understanding maternal and feto-neonatal side effects is crucial for treatment safety.
• Previous studies report varying degrees of adverse events associated with these treatments.

Purpose of the Study:

• To evaluate the incidence and severity of maternal and feto-neonatal side effects.
• To assess the safety profile of combined tocolytic and corticosteroid therapy.
• To compare observed side effects with findings from other research.

Main Methods:

• Retrospective analysis of maternal and feto-neonatal outcomes.
• Observation of side effects following administration of corticosteroids and beta-mimetic drugs.
• Data collection at the Institute of Obstetrics and Gynecology, University of Parma.

Main Results:

• A low rate of maternal side effects was observed, with significantly lower severity compared to other studies.
• Fetal and neonatal side effects were infrequent.
• Causality between observed feto-neonatal symptoms and the therapy could not be definitively established, with multiple potential contributing factors.

Conclusions:

• The observed maternal, fetal, and neonatal side effects were not severe enough to render the tocolytic and corticosteroid treatment unacceptable.
• The study supports the cautious use of these medications in specific obstetric scenarios.
• Further research may be needed to clarify the etiology of rare feto-neonatal symptoms.